Neoadjuvant relatlimab and nivolumab in resectable melanoma (vol 611, pg 155, 2022)

被引：1
|
作者：
Amaria, Rodabe N.
Postow, Michael
Burton, Elizabeth M.
Tetzlaff, Michael T.
Ross, Merrick I.
Torres-Cabala, Carlos
Glitza, Isabella C.
Duan, Fei
Milton, Denai R.
Busam, Klaus
Simpson, Lauren
McQuade, Jennifer L.
Wong, Michael K.
Gershenwald, Jeffrey E.
Lee, Jeffrey E.
Goepfert, Ryan P.
Keung, Emily Z.
Fisher, Sarah B.
Betof-Warner, Allison
Shoushtari, Alexander N.
Callahan, Margaret
Coit, Daniel
Bartlett, Edmund K.
Bello, Danielle
Momtaz, Parisa
Nicholas, Courtney
Gu, Aidi
Zhang, Xuejun
Korivi, Brinda Rao
Patnana, Madhavi
Patel, Sapna P.
Diab, Adi
Lucci, Anthony
Prieto, Victor G.
Davies, Michael A.
Allison, James P.
Sharma, Padmanee
Wargo, Jennifer A.
Ariyan, Charlotte
Tawbi, Hussein A.
机构：
来源：
NATURE | 2023年 / 615卷 / 7953期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/s41586-023-05892-1
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Rodabe N. Amaria
    Michael Postow
    Elizabeth M. Burton
    Michael T. Tetzlaff
    Merrick I. Ross
    Carlos Torres-Cabala
    Isabella C. Glitza
    Fei Duan
    Denái R. Milton
    Klaus Busam
    Lauren Simpson
    Jennifer L. McQuade
    Michael K. Wong
    Jeffrey E. Gershenwald
    Jeffrey E. Lee
    Ryan P. Goepfert
    Emily Z. Keung
    Sarah B. Fisher
    Allison Betof-Warner
    Alexander N. Shoushtari
    Margaret Callahan
    Daniel Coit
    Edmund K. Bartlett
    Danielle Bello
    Parisa Momtaz
    Courtney Nicholas
    Aidi Gu
    Xuejun Zhang
    Brinda Rao Korivi
    Madhavi Patnana
    Sapna P. Patel
    Adi Diab
    Anthony Lucci
    Victor G. Prieto
    Michael A. Davies
    James P. Allison
    Padmanee Sharma
    Jennifer A. Wargo
    Charlotte Ariyan
    Hussein A. Tawbi
    Nature, 2022, 611 : 155 - 160
  • [2] Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Amaria, Rodabe N.
    Postow, Michael
    Burton, Elizabeth M.
    Tezlaff, Michael T.
    Ross, Merrick, I
    Torres-Cabala, Carlos
    Glitza, Isabella C.
    Duan, Fei
    Milton, Denai R.
    Busam, Klaus
    Simpson, Lauren
    McQuade, Jennifer L.
    Wong, Michael K.
    Gershenwald, Jeffrey E.
    Lee, Jeffrey E.
    Goepfert, Ryan P.
    Keung, Emily Z.
    Fisher, Sarah B.
    Betof-Warner, Allison
    Shoushtari, Alexander N.
    Callahan, Margaret
    Coit, Daniel
    Bartlett, Edmund K.
    Bello, Danielle
    Momtaz, Parisa
    Nicholas, Courtney
    Gu, Aidi
    Zhang, Xuejun
    Korivi, Brinda Rao
    Patnana, Madhavi
    Patel, Sapna P.
    Diab, Adi
    Lucci, Anthony
    Prieto, Victor G.
    Davies, Michael A.
    Allison, James P.
    Sharma, Padmanee
    Wargo, Jennifer A.
    Ariyan, Charlotte
    Tawbi, Hussein A.
    NATURE, 2022, 611 (7934) : 155 - +
  • [3] Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Rodabe N. Amaria
    Michael Postow
    Elizabeth M. Burton
    Michael T. Tetzlaff
    Merrick I. Ross
    Carlos Torres-Cabala
    Isabella C. Glitza
    Fei Duan
    Denái R. Milton
    Klaus Busam
    Lauren Simpson
    Jennifer L. McQuade
    Michael K. Wong
    Jeffrey E. Gershenwald
    Jeffrey E. Lee
    Ryan P. Goepfert
    Emily Z. Keung
    Sarah B. Fisher
    Allison Betof-Warner
    Alexander N. Shoushtari
    Margaret Callahan
    Daniel Coit
    Edmund K. Bartlett
    Danielle Bello
    Parisa Momtaz
    Courtney Nicholas
    Aidi Gu
    Xuejun Zhang
    Brinda Rao Korivi
    Madhavi Patnana
    Sapna P. Patel
    Adi Diab
    Anthony Lucci
    Victor G. Prieto
    Michael A. Davies
    James P. Allison
    Padmanee Sharma
    Jennifer A. Wargo
    Charlotte Ariyan
    Hussein A. Tawbi
    Nature, 2023, 615 (7953) : E23 - E23
  • [4] Real-world efficacy of relatlimab and nivolumab in advanced or resectable melanoma
    Karapetyan, L.
    Aflatooni, S.
    Ward, K.
    Withycombe, B.
    Kalos, D.
    Mo, Q.
    Eroglu, Z.
    Brohl, A. S.
    Markowitz, J.
    Tarhini, A.
    Messina, J.
    Tsai, K. Y.
    Perez, M.
    Zager, J. S.
    Sarnaik, A.
    Neves, R. I.
    Sondak, V.
    Khushalani, N. I.
    ANNALS OF ONCOLOGY, 2024, 35 : S731 - S731
  • [5] Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma
    Burton, Elizabeth M.
    Wani, Khalida M.
    Milton, Denai R.
    Segura, Rossana Lazcano
    Tetzlaff, Michael
    Ross, Merrick I.
    Postow, Michael A.
    Glitza, Isabella Claudia
    Wong, Michael K. K.
    Diab, Adi
    Gershenwald, Jeffrey E.
    Patel, Sapna Pradyuman
    McQuade, Jennifer Leigh
    Prieto, Victor Gerardo
    Ariyan, Charlotte Eielson
    Lazar, Alexander J.
    Wargo, Jennifer Ann
    Tawbi, Hussein A.
    Amaria, Rodabe Navroze
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
    Blank, Christian U.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta
    Hoeijmakers, Lotte L.
    Saw, Robyn P. M.
    Lijnsvelt, Judith M.
    Maher, Nigel G.
    Pulleman, Saskia M.
    Gonzalez, Maria
    Torres Acosta, Alejandro
    van Houdt, Winan J.
    Lo, Serigne N.
    Kuijpers, Anke M. J.
    Spillane, Andrew
    Klop, W. Martin C.
    Pennington, Thomas E.
    Zuur, Charlotte L.
    Shannon, Kerwin F.
    Seinstra, Beatrijs A.
    Rawson, Robert V.
    Haanen, John B. A. G.
    Ch'ng, Sydney
    Naipal, Kishan A. T.
    Stretch, Jonathan
    van Thienen, Johannes V.
    Rtshiladze, Michael A.
    Wilgenhof, Sofie
    Kapoor, Rony
    Meerveld-Eggink, Aafke
    Grijpink-Ongering, Lindsay G.
    van Akkooi, Alexander C. J.
    Reijers, Irene L. M.
    Gyorki, David E.
    Gruenhagen, Dirk J.
    Speetjens, Frank M.
    Vliek, Sonja B.
    Placzke, Joanna
    Spain, Lavinia
    Stassen, Robert C.
    Amini-Adle, Mona
    Lebbe, Celeste
    Faries, Mark B.
    Robert, Caroline
    Ascierto, Paolo A.
    van Rijn, Rozemarijn
    van den Berkmortel, Franchette W. P. J.
    Piersma, Djura
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1696 - 1708
  • [7] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
    Blank, Christian U.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta
    Hoeijmakers, Lotte L.
    Saw, Robyn P. M.
    Lijnsvelt, Judith M.
    Maher, Nigel G.
    Pulleman, Saskia M.
    Gonzalez, Maria
    Acosta, Alejandro Torres
    van Houdt, Winan J.
    Lo, Serigne N.
    Kuijpers, Anke M. J.
    Spillane, Andrew
    Klop, W. Martin C.
    Pennington, Thomas E.
    Zuur, Charlotte L.
    Shannon, Kerwin F.
    Seinstra, Beatrijs A.
    Rawson, Robert V.
    Haanen, John B. A. G.
    Ch'ng, Sydney
    Naipal, Kishan A. T.
    Stretch, Jonathan
    van Thienen, Johannes V.
    Rtshiladze, Michael A.
    Wilgenhof, Sofie
    Kapoor, Rony
    Meerveld-Eggink, Aafke
    Grijpink-Ongering, Lindsay G.
    van Akkooi, Alexander C. J.
    Reijers, Irene L. M.
    Gyorki, David E.
    Gruenhagen, Dirk J.
    Speetjens, Frank M.
    Vliek, Sonja B.
    Placzke, Joanna
    Spain, Lavinia
    Stassen, Robert C.
    Amini-Adle, Mona
    Lebbe, Celeste
    Faries, Mark B.
    Robert, Caroline
    Ascierto, Paolo A.
    van Rijn, Rozemarijn
    van den Berkmortel, Franchette W. P. J.
    Piersma, Djura
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [8] Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up
    Cuppens, K.
    Baas, P.
    Wiesweg, M.
    Du Pont, B.
    Ploenes, T.
    Theegarten, D.
    Aigner, C.
    Hartemink, K.
    Maes, B.
    Pat, K.
    Schuler, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S9 - S9
  • [9] Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).
    Ferris, Robert L.
    Gooding, William E.
    Chiosea, Simion I.
    Duvvuri, Umamaheswar
    Kim, Seungwon
    Kubik, Mark
    Sridharan, Shaum
    Fenton, Moon Jung
    Skinner, Heath Devin
    Kelly, Zahra Rahman
    Li, Housaiyin
    Vujanovic, Lazar
    Zandberg, Dan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma
    Lowe, M.
    Yushak, M. L.
    Olson, B.
    Mokhtari, A.
    Harutyunyan, A.
    Delman, K.
    Parker, D.
    Evans, E.
    Fisher, T.
    Lesinski, G.
    Kudchadkar, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S906 - S906
12345